Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: an integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study
Gradually, vertical lines form on our foreheads, at the corners of our eyes, and around our mouths
CVOTs have shown that GLP-1 receptor agonists reduce MACE in patients with T2D compared to placebo
Enhanced immune system and faster recovery
It was advanced to clinical trial designations (PL-10, PL14736) for IBD
US$ 21.42
US$ 28.11
US$ 24.89
US$ 21.09
